5-chloromethylfluorescein diacetate has been researched along with Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balamurugan, R; Rajeswari, R; Ramakrishna, S; Shayanti, M; Sridhar, R; Sundarrajan, S; Venugopal, J | 1 |
| Doubek, M; Dusek, L; Groch, L; Hornácek, I; Klabusay, M; Korístek, Z; Kren, L; Lexmaulová, L; Mayer, J; Meluzín, J; Palsa, S; Pospísilová, S; Rauser, P; Sitar, J; Tichý, B; Vlasín, M | 1 |
2 other study(ies) available for 5-chloromethylfluorescein diacetate and Myocardial Infarction
| Article | Year |
|---|---|
Xylan polysaccharides fabricated into nanofibrous substrate for myocardial infarction.
Topics: Animals; Cell Proliferation; Cell Shape; Cross-Linking Reagents; Fluoresceins; Glutaral; Immunohistochemistry; Materials Testing; Myocardial Infarction; Myocytes, Cardiac; Nanofibers; Polyvinyl Alcohol; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Tensile Strength; Tissue Engineering; Tissue Scaffolds; Xylans | 2013 |
Intracoronary delivery of bone marrow cells to the acutely infarcted myocardium. Optimization of the delivery technique.
Topics: Animals; Bone Marrow Transplantation; Cardiac Catheterization; Catheterization; Disease Models, Animal; Female; Fluoresceins; Fluorescent Dyes; Male; Microscopy, Fluorescence; Myocardial Infarction; Swine | 2009 |